JONATHAN SILVERSTEIN Insider Trading Transactions
Get free email notifications about insider trading for JONATHAN SILVERSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN SILVERSTEIN. JONATHAN SILVERSTEIN is Director in AVANIR PHARMACEUTICALS, INC. ($AVNR) and in GLAUKOS Corp ($GKOS) and Director in GLAUKOS Corp ($GKOS) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in AVEDRO INC ($AVDR) and Director in Roka BioScience, Inc. ($ROKA) and Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in resTORbio, Inc. ($TORC) and Director in Arcutis Biotherapeutics, Inc. ($ARQT).
Latest Insider Trading Transactions of JONATHAN SILVERSTEIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ARQT, BOLD, AVNR, AVDR, GKOS, ICPT, SCPH, ROKA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 296,000 | 7,400,000 | 902,286 | 606.3 K to 902.3 K (+48.82 %) |
Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 200,000 | 5,000,000 | 4,267,564 | 4.1 M to 4.3 M (+4.92 %) |
Jun 05 2020 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 2.23 | 14,414 | 32,143 | 14,414 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | D | 0.00 | 3,005 | 0 | 0 | |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | D | 0.00 | 3,005 | 0 | 0 | |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | D | 12.73 | 8,314 | 105,837 | 0 | |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | D | 12.73 | 8,314 | 105,837 | 0 | |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Sell | D | 0.00 | 4,240,128 | 0 | 0 | 4.2 M to 0 (-100.00 %) |
Nov 25 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Sell | D | 0.00 | 4,240,128 | 0 | 0 | 4.2 M to 0 (-100.00 %) |
Jun 18 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 0.00 | 3,005 | 0 | 3,005 | |
May 09 2019 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 7.99 | 14,414 | 115,168 | 14,414 | |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 12.73 | 8,314 | 105,837 | 8,314 | |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 383,746 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 333,178 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 3,370,786 | 0 | 0 | |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 383,746 | 0 | 4,240,128 | 3.9 M to 4.2 M (+9.95 %) |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 333,178 | 0 | 3,856,382 | 3.5 M to 3.9 M (+9.46 %) |
Feb 19 2019 | AVDR | AVEDRO INC | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 3,370,786 | 0 | 3,523,204 | 152.4 K to 3.5 M (+2,211.54 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.06 | 445 | 14,267 | 0 | 445 to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.06 | 46,676 | 1,496,433 | 0 | 46.7 K to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.77 | 192 | 5,908 | 445 | 637 to 445 (-30.14 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.77 | 20,114 | 618,908 | 46,676 | 66.8 K to 46.7 K (-30.12 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.01 | 886 | 26,589 | 637 | 1.5 K to 637 (-58.17 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.01 | 93,008 | 2,791,170 | 66,790 | 159.8 K to 66.8 K (-58.20 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.06 | 768 | 25,390 | 1,523 | 2.3 K to 1.5 K (-33.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.06 | 80,516 | 2,661,859 | 159,798 | 240.3 K to 159.8 K (-33.50 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.05 | 1,220 | 39,101 | 2,291 | 3.5 K to 2.3 K (-34.75 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.05 | 128,092 | 4,105,349 | 240,314 | 368.4 K to 240.3 K (-34.77 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.80 | 1,851 | 60,713 | 3,511 | 5.4 K to 3.5 K (-34.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.80 | 194,433 | 6,377,402 | 368,406 | 562.8 K to 368.4 K (-34.55 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 31.92 | 2,533 | 80,853 | 5,362 | 7.9 K to 5.4 K (-32.08 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 31.92 | 265,766 | 8,483,251 | 562,839 | 828.6 K to 562.8 K (-32.07 %) |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,871,569 | 0 | 0 | |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,425,482 | 0 | 0 | |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 533,333 | 7,999,995 | 4,830,387 | 4.3 M to 4.8 M (+12.41 %) |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,871,569 | 0 | 4,297,054 | 2.4 M to 4.3 M (+77.16 %) |
Jan 30 2018 | TORC | resTORbio, Inc. | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,425,485 | 0 | 2,425,485 | 0 to 2.4 M |
Dec 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Option Exercise | A | 25.77 | 15,000 | 386,550 | 15,000 | ||
Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 40.77 | 553 | 22,546 | 7,895 | 8.4 K to 7.9 K (-6.55 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 40.77 | 58,047 | 2,366,576 | 828,605 | 886.7 K to 828.6 K (-6.55 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 39.63 | 1,808 | 71,651 | 8,448 | 10.3 K to 8.4 K (-17.63 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 39.63 | 189,792 | 7,521,457 | 886,652 | 1.1 M to 886.7 K (-17.63 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.94 | 1,651 | 62,639 | 10,256 | 11.9 K to 10.3 K (-13.87 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.94 | 173,349 | 6,576,861 | 1,076,444 | 1.2 M to 1.1 M (-13.87 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.72 | 1,038 | 39,153 | 11,907 | 12.9 K to 11.9 K (-8.02 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.72 | 109,040 | 4,112,989 | 1,249,793 | 1.4 M to 1.2 M (-8.02 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.82 | 424 | 16,036 | 12,945 | 13.4 K to 12.9 K (-3.17 %) |
Sep 05 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.82 | 44,498 | 1,682,914 | 1,358,833 | 1.4 M to 1.4 M (-3.17 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.85 | 2,140 | 80,999 | 13,369 | 15.5 K to 13.4 K (-13.80 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 37.85 | 224,780 | 8,507,923 | 1,403,331 | 1.6 M to 1.4 M (-13.81 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 38.01 | 619 | 23,528 | 15,509 | 16.1 K to 15.5 K (-3.84 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 38.01 | 64,961 | 2,469,168 | 1,628,111 | 1.7 M to 1.6 M (-3.84 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 38.29 | 307 | 11,755 | 16,128 | 16.4 K to 16.1 K (-1.87 %) |
Aug 17 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 38.29 | 32,193 | 1,232,670 | 1,693,072 | 1.7 M to 1.7 M (-1.87 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 44.54 | 699 | 31,133 | 16,435 | 17.1 K to 16.4 K (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 44.54 | 73,401 | 3,269,281 | 1,725,265 | 1.8 M to 1.7 M (-4.08 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 46.13 | 7 | 323 | 17,134 | 17.1 K to 17.1 K (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 46.13 | 693 | 31,968 | 1,798,666 | 1.8 M to 1.8 M (-0.04 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.30 | 1,998 | 90,509 | 17,141 | 19.1 K to 17.1 K (-10.44 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.30 | 208,712 | 9,454,654 | 1,799,359 | 2 M to 1.8 M (-10.39 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.98 | 915 | 42,072 | 19,129 | 20 K to 19.1 K (-4.56 %) |
Mar 14 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 45.98 | 96,113 | 4,419,276 | 2,008,071 | 2.1 M to 2 M (-4.57 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 47.05 | 526 | 24,748 | 20,044 | 20.6 K to 20 K (-2.56 %) |
Mar 07 2017 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 47.05 | 55,246 | 2,599,324 | 2,104,184 | 2.2 M to 2.1 M (-2.56 %) |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 53,909 | 0 | 53,909 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 5,660,377 | 0 | 5,660,377 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 38 | 0 | 38 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 3,962 | 0 | 3,962 | |
Aug 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 15.03 | 18,000 | 270,540 | 18,000 | |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.72 | 133 | 4,485 | 20,570 | 20.7 K to 20.6 K (-0.64 %) |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.72 | 13,967 | 470,967 | 2,159,430 | 2.2 M to 2.2 M (-0.64 %) |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.63 | 1,518 | 51,050 | 20,703 | 22.2 K to 20.7 K (-6.83 %) |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.63 | 159,382 | 5,360,017 | 2,173,397 | 2.3 M to 2.2 M (-6.83 %) |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.77 | 1,113 | 37,586 | 22,221 | 23.3 K to 22.2 K (-4.77 %) |
Aug 12 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.77 | 116,825 | 3,945,180 | 2,332,779 | 2.4 M to 2.3 M (-4.77 %) |
Aug 05 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.59 | 4,010 | 122,666 | 23,334 | 27.3 K to 23.3 K (-14.67 %) |
Aug 05 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.59 | 420,990 | 12,878,084 | 2,449,604 | 2.9 M to 2.4 M (-14.67 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 332,766 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,071,992 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,511,441 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 627,867 | 0 | 0 | |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | P | 15.00 | 33,334 | 500,010 | 4,801,638 | 4.8 M to 4.8 M (+0.70 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 332,766 | 0 | 4,768,304 | 4.4 M to 4.8 M (+7.50 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,071,992 | 0 | 4,435,538 | 3.4 M to 4.4 M (+31.87 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,511,441 | 0 | 3,363,546 | 852.1 K to 3.4 M (+294.73 %) |
Jul 25 2016 | BOLD | Audentes Therapeut ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 627,867 | 0 | 852,105 | 224.2 K to 852.1 K (+280.00 %) |
Jun 24 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 03 2016 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Option Exercise | A | 24.69 | 15,000 | 370,350 | 15,000 | ||
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Grant | A | 0.00 | 650 | 0 | 1,259 | 609 to 1.3 K (+106.73 %) |
Jul 24 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 32.00 | 25,000 | 800,000 | 25,000 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | M | 7.65 | 261 | 1,997 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | M | 7.65 | 27,346 | 209,197 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,672 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 280,531 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 1,599 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 167,898 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 22,923 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,406,441 | 0 | 0 | |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Payment of Exercise | F | 18.00 | 111 | 1,998 | 27,344 | 27.5 K to 27.3 K (-0.40 %) |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Buy | M | 0.00 | 261 | 0 | 27,455 | 27.2 K to 27.5 K (+0.96 %) |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Payment of Exercise | F | 18.00 | 11,623 | 209,214 | 2,870,593 | 2.9 M to 2.9 M (-0.40 %) |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Buy | M | 0.00 | 27,346 | 0 | 2,882,216 | 2.9 M to 2.9 M (+0.96 %) |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 27,194 | 0 | 27,194 | 0 to 27.2 K |
Jun 30 2015 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,854,870 | 0 | 2,854,870 | 0 to 2.9 M |
Jun 26 2015 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 294.82 | 90 | 26,534 | 1,120,324 | 1.1 M to 1.1 M (-0.01 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 293.85 | 2,500 | 734,625 | 1,120,414 | 1.1 M to 1.1 M (-0.22 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 292.13 | 6,000 | 1,752,780 | 1,122,914 | 1.1 M to 1.1 M (-0.53 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 291.12 | 3,700 | 1,077,144 | 1,128,914 | 1.1 M to 1.1 M (-0.33 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 290.02 | 13,974 | 4,052,739 | 1,132,614 | 1.1 M to 1.1 M (-1.22 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 289.07 | 15,131 | 4,373,918 | 1,146,588 | 1.2 M to 1.1 M (-1.30 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 288.11 | 26,028 | 7,498,927 | 1,161,719 | 1.2 M to 1.2 M (-2.19 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 287.16 | 18,041 | 5,180,654 | 1,187,747 | 1.2 M to 1.2 M (-1.50 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 286.24 | 7,611 | 2,178,573 | 1,205,788 | 1.2 M to 1.2 M (-0.63 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 285.18 | 23,903 | 6,816,658 | 1,213,399 | 1.2 M to 1.2 M (-1.93 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 284.20 | 16,845 | 4,787,349 | 1,237,302 | 1.3 M to 1.2 M (-1.34 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 282.87 | 9,357 | 2,646,815 | 1,254,147 | 1.3 M to 1.3 M (-0.74 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 282.13 | 8,397 | 2,369,046 | 1,263,504 | 1.3 M to 1.3 M (-0.66 %) |
Mar 30 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 281.11 | 5,623 | 1,580,682 | 1,271,901 | 1.3 M to 1.3 M (-0.44 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 270.23 | 2,800 | 756,644 | 1,277,524 | 1.3 M to 1.3 M (-0.22 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 275.56 | 3,844 | 1,059,253 | 1,280,324 | 1.3 M to 1.3 M (-0.30 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 275.00 | 12,066 | 3,318,150 | 1,284,168 | 1.3 M to 1.3 M (-0.93 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 273.19 | 2,700 | 737,613 | 1,296,234 | 1.3 M to 1.3 M (-0.21 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 272.13 | 3,050 | 829,997 | 1,298,934 | 1.3 M to 1.3 M (-0.23 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 271.15 | 6,063 | 1,643,982 | 1,301,984 | 1.3 M to 1.3 M (-0.46 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 270.13 | 9,574 | 2,586,225 | 1,308,047 | 1.3 M to 1.3 M (-0.73 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 269.10 | 1,539 | 414,145 | 1,317,621 | 1.3 M to 1.3 M (-0.12 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 268.13 | 6,764 | 1,813,631 | 1,319,160 | 1.3 M to 1.3 M (-0.51 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 288.60 | 1,000 | 288,600 | 1,325,924 | 1.3 M to 1.3 M (-0.08 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 286.04 | 1,400 | 400,456 | 1,326,924 | 1.3 M to 1.3 M (-0.11 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 283.44 | 52 | 14,739 | 1,328,324 | 1.3 M to 1.3 M (0.00 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 283.29 | 1,548 | 438,533 | 1,328,376 | 1.3 M to 1.3 M (-0.12 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 282.00 | 3,500 | 987,000 | 1,329,924 | 1.3 M to 1.3 M (-0.26 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 281.01 | 6,306 | 1,772,049 | 1,333,424 | 1.3 M to 1.3 M (-0.47 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 280.00 | 9,465 | 2,650,200 | 1,339,730 | 1.3 M to 1.3 M (-0.70 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 279.00 | 3,668 | 1,023,372 | 1,349,195 | 1.4 M to 1.3 M (-0.27 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 278.00 | 14,152 | 3,934,256 | 1,352,863 | 1.4 M to 1.4 M (-1.04 %) |
Mar 25 2015 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 276.96 | 8,195 | 2,269,687 | 1,367,015 | 1.4 M to 1.4 M (-0.60 %) |